School of Medicine

Researchers at the School of Medicine have analyzed Medicare claims data of more than 200,000 people to develop an algorithm to predict whether a patient one day will be diagnosed with Parkinson’s.

The School of Medicine’s innovative program to introduce lay people to the world of medicine will get underway again later this month. Register now to take part in Mini-Medical School, a series of lectures and hands-on labs on everything from surgery to back pain to Alzheimer’s disease.

Philip D. Stahl, the Edward Mallinckrodt Jr. Professor Emeritus of Cell Biology and Physiology and former director of the Division of Biology & Biomedical Sciences at Washington University in St. Louis, has received a Special Achievement Award from the International Society for Extracellular Vesicles. 

Researchers at the School of Medicine are recruiting volunteers for a national study that is exploring whether strategies to improve cardiovascular health also reduce the risk of dementia in those at risk for Alzheimer’s disease.

Sasa Mutic, professor of radiation oncology, has been named vice chair of medical physics and clinical strategy at Washington University School of Medicine in St. Louis.

Research at Washington University School of Medicine in St. Louis has identified immune signaling molecules that are essential for activating neurons in the skin to cause chronic itching.

Scientists at the School of Medicine have converted skin cells from healthy adults directly into motor neurons without going through a stem cell state.

The TL1 Translational Sciences Postdoctoral Program is recruiting postdoctoral researchers to fill training grant slots under the Clinical Translational Science Awards. Funding is available to trainees.

Matthew A. Ciorba, MD, of the Division of Gastroenterology at Washington University School of Medicine in St. Louis, has been named chief of the division’s Inflammatory Bowel Disease Program.

New research from the School of Medicine in St. Louis and the University of California San Diego School of Medicine shows that the Zika virus can kill brain cancer stem cells, the kind of cells most resistant to standard treatments.